JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

dacomitinib

Lung cancer medicine receives positive opinion in the EU

Posted: February 07, 2019

|

Categories: Updates

|

Tags: vizimpro , lung cancer , dacomitinib , chmp

|

Author: Joanna Bankersingh

CHMP's assessment supports EMA's approval of non-small cell lung cancer (NSCLC) medicine, Vizimpro (dacomitinib).

Read more »